HRP20031067B1 - Pharmaceutical formulation having masked taste and method for the production thereof - Google Patents

Pharmaceutical formulation having masked taste and method for the production thereof

Info

Publication number
HRP20031067B1
HRP20031067B1 HR20031067A HRP20031067A HRP20031067B1 HR P20031067 B1 HRP20031067 B1 HR P20031067B1 HR 20031067 A HR20031067 A HR 20031067A HR P20031067 A HRP20031067 A HR P20031067A HR P20031067 B1 HRP20031067 B1 HR P20031067B1
Authority
HR
Croatia
Prior art keywords
pharmaceutical formulation
production
masked taste
soluble
practically insoluble
Prior art date
Application number
HR20031067A
Other languages
English (en)
Croatian (hr)
Inventor
Becourt Philippe
Chauvin Josiane
Schwabe Detlev
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of HRP20031067A2 publication Critical patent/HRP20031067A2/xx
Publication of HRP20031067B1 publication Critical patent/HRP20031067B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20031067A 2001-06-21 2002-06-21 Pharmaceutical formulation having masked taste and method for the production thereof HRP20031067B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0108157A FR2826274B1 (fr) 2001-06-21 2001-06-21 Formulation pharmaceutique au gout masque et son procede de preparation
PCT/FR2002/002158 WO2003000225A2 (fr) 2001-06-21 2002-06-21 Formulation pharmaceutique au gout masque et son procede de preparation

Publications (2)

Publication Number Publication Date
HRP20031067A2 HRP20031067A2 (en) 2004-04-30
HRP20031067B1 true HRP20031067B1 (en) 2011-10-31

Family

ID=8864587

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20031067A HRP20031067B1 (en) 2001-06-21 2002-06-21 Pharmaceutical formulation having masked taste and method for the production thereof

Country Status (41)

Country Link
US (2) US7138138B2 (enExample)
EP (1) EP1401397B1 (enExample)
JP (1) JP4880871B2 (enExample)
CN (1) CN1239149C (enExample)
AP (1) AP1595A (enExample)
AR (1) AR036096A1 (enExample)
AT (1) ATE290366T1 (enExample)
AU (1) AU2002329311B2 (enExample)
BG (1) BG66314B1 (enExample)
BR (1) BRPI0208998A2 (enExample)
CA (1) CA2452239C (enExample)
CO (1) CO5540278A2 (enExample)
CZ (1) CZ299947B6 (enExample)
DE (1) DE60203178T2 (enExample)
EA (1) EA006016B1 (enExample)
EC (1) ECSP034915A (enExample)
ES (1) ES2236574T3 (enExample)
FR (1) FR2826274B1 (enExample)
GT (2) GT200200115AA (enExample)
HR (1) HRP20031067B1 (enExample)
HU (1) HUP0400799A3 (enExample)
IL (2) IL159404A0 (enExample)
JO (1) JO2325B1 (enExample)
MA (1) MA27042A1 (enExample)
MX (1) MXPA03011756A (enExample)
MY (1) MY134340A (enExample)
NO (1) NO332258B1 (enExample)
NZ (1) NZ530042A (enExample)
OA (1) OA12635A (enExample)
PA (1) PA8548301A1 (enExample)
PE (1) PE20030201A1 (enExample)
PL (1) PL202090B1 (enExample)
PT (1) PT1401397E (enExample)
SK (1) SK285865B6 (enExample)
SV (1) SV2003001098A (enExample)
TN (1) TNSN03141A1 (enExample)
TW (1) TWI228049B (enExample)
UA (1) UA77960C2 (enExample)
UY (1) UY27341A1 (enExample)
WO (1) WO2003000225A2 (enExample)
ZA (1) ZA200309479B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7384921B2 (en) * 2004-02-20 2008-06-10 Enanta Pharmaceuticals, Inc. Polymorphic forms of 6-11 bicyclic ketolide derivatives
GB2419094A (en) 2004-10-12 2006-04-19 Sandoz Ag Pharmaceutical composition of unpleasnt tasing active substances
FR2882522B1 (fr) * 2005-02-25 2007-04-13 Aventis Pharma Sa Composition pharmaceutique solide comprenant de la telithromycine
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
US20060264386A1 (en) * 2005-05-17 2006-11-23 Rongqi Sun Pharmaceutical formulations of 6-11 bicyclic ketolide derivatives and related macrolides and methods for preparation thereof
CN101370480A (zh) * 2006-02-03 2009-02-18 赢创罗姆有限责任公司 含有由聚合物和在水中溶解较差的活性成分组成的混合物的药物组合物
WO2007108010A2 (en) * 2006-03-21 2007-09-27 Jubilant Organosys Limited Taste masked pharmaceutical composition for oral solid dosage form and process for preparing the same using magnesium aluminium silicate
WO2008094877A2 (en) * 2007-01-30 2008-08-07 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
KR100935893B1 (ko) * 2007-09-11 2010-01-07 국방과학연구소 1,1'-다이메틸-5,5’-바이테트라졸의 합성방법
CA2703475A1 (en) 2007-10-25 2009-04-30 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
EA021761B9 (ru) 2008-12-16 2015-12-30 Карлсберг А/С Полимерный материал на основе целлюлозы
CN104470527B (zh) 2012-03-27 2019-05-28 森普拉制药公司 用于施用大环内酯抗生素的肠胃外制剂
DE102012014848A1 (de) * 2012-07-27 2012-10-31 Heilerde-Gesellschaft Luvos Just GmbH & Co. KG Heilerde-Zubereitung
BR112017002335A2 (pt) * 2014-08-05 2018-01-16 Cempra Pharmaceuticals, Inc. formulações de suspensão oral em pó de agentes antibacterianos
US10982177B2 (en) 2017-09-18 2021-04-20 The Clorox Company Cleaning wipes with particular lotion retention and efficacy characteristics
CN114209661B (zh) * 2022-02-21 2022-04-29 北京罗诺强施医药技术研发中心有限公司 呈细粒形式的固体药物组合物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293885A2 (en) * 1987-06-05 1988-12-07 Abbott Laboratories Antibiotic-polymer compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
WO1999017742A2 (en) * 1997-10-03 1999-04-15 Elan Corporation, Plc Taste masked formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2930409A1 (de) * 1979-07-26 1981-02-12 Bayer Ag Spruehtrocknung von mikrokapseldispersionen
JPS63150220A (ja) * 1986-12-15 1988-06-22 Dainippon Pharmaceut Co Ltd 経口用固形製剤の製造方法
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
AUPN969796A0 (en) * 1996-05-07 1996-05-30 F.H. Faulding & Co. Limited Taste masked liquid suspensions
IN191239B (enExample) * 1999-06-11 2003-10-11 Ranbaxy Lab Ltd
US6555569B2 (en) * 2000-03-07 2003-04-29 Pfizer Inc. Use of heteroaryl substituted N-(indole-2-carbonyl-) amides for treatment of infection
EP1313751B1 (en) * 2000-08-22 2008-09-17 Basilea Pharmaceutica AG New macrolides with antibacterial activity

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293885A2 (en) * 1987-06-05 1988-12-07 Abbott Laboratories Antibiotic-polymer compositions
US5084278A (en) * 1989-06-02 1992-01-28 Nortec Development Associates, Inc. Taste-masked pharmaceutical compositions
WO1999017742A2 (en) * 1997-10-03 1999-04-15 Elan Corporation, Plc Taste masked formulations

Also Published As

Publication number Publication date
ZA200309479B (en) 2005-04-26
DE60203178D1 (de) 2005-04-14
FR2826274B1 (fr) 2003-09-26
OA12635A (fr) 2006-06-15
US20070014857A1 (en) 2007-01-18
NZ530042A (en) 2005-09-30
JP2004534810A (ja) 2004-11-18
HK1067558A1 (en) 2005-04-15
EA200400061A1 (ru) 2004-06-24
JP4880871B2 (ja) 2012-02-22
US20040142029A1 (en) 2004-07-22
BG66314B1 (bg) 2013-04-30
HUP0400799A3 (en) 2012-08-28
HUP0400799A2 (hu) 2004-08-30
EP1401397B1 (fr) 2005-03-09
CZ299947B6 (cs) 2009-01-07
AP1595A (en) 2006-04-12
CA2452239A1 (fr) 2003-01-03
ES2236574T3 (es) 2005-07-16
AR036096A1 (es) 2004-08-11
CN1239149C (zh) 2006-02-01
MY134340A (en) 2007-12-31
BG108458A (bg) 2005-02-28
SV2003001098A (es) 2003-03-18
IL159404A (en) 2007-08-19
CN1529585A (zh) 2004-09-15
PA8548301A1 (es) 2003-09-05
GT200200115A (es) 2003-02-27
ATE290366T1 (de) 2005-03-15
DE60203178T2 (de) 2006-01-26
CZ20033441A3 (en) 2004-03-17
WO2003000225A3 (fr) 2003-03-13
AU2002329311B2 (en) 2007-02-01
PL366803A1 (en) 2005-02-07
AP2003002927A0 (en) 2003-12-31
JO2325B1 (en) 2006-06-28
CA2452239C (fr) 2011-07-19
IL159404A0 (en) 2004-06-01
FR2826274A1 (fr) 2002-12-27
UA77960C2 (en) 2007-02-15
BRPI0208998A2 (pt) 2017-06-06
EA006016B1 (ru) 2005-08-25
MA27042A1 (fr) 2004-12-20
MXPA03011756A (es) 2004-07-01
GT200200115AA (es) 2005-01-12
PL202090B1 (pl) 2009-06-30
SK285865B6 (sk) 2007-10-04
PT1401397E (pt) 2005-05-31
TWI228049B (en) 2005-02-21
HRP20031067A2 (en) 2004-04-30
NO332258B1 (no) 2012-08-13
ECSP034915A (es) 2004-02-26
CO5540278A2 (es) 2005-07-29
TNSN03141A1 (fr) 2005-12-23
UY27341A1 (es) 2003-01-31
PE20030201A1 (es) 2003-03-12
NO20035581D0 (no) 2003-12-15
SK15922003A3 (sk) 2004-05-04
WO2003000225A2 (fr) 2003-01-03
EP1401397A2 (fr) 2004-03-31
US7138138B2 (en) 2006-11-21

Similar Documents

Publication Publication Date Title
ATE258432T1 (de) Geschmacksmaskierte flüssige suspensionen
WO2005000267A3 (en) Spray drying of an alcoholic aqueous solution for the manufacture of a water-insoluble active agentmicroparticle with a partial or complete amino acid and/or phospholipid coat
CA2415643A1 (en) Pharmaceutical composition for oral use with improved absorption
WO2003035051A3 (en) The use of proton sequestering agents in drug formulations
ATE544447T1 (de) Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
CA2294457A1 (en) Pharmaceutical composition for application to mucosa
ATE130511T1 (de) Gefriergetrocknete polymerdispersionen und ihre anwendung zur darstellung von arzneimittelzubereitungen mit protrahierter wirkstoffabgabe.
ATE324871T1 (de) Neue formulierung mit modifizierter freisetzung
CA2164776A1 (en) Pharmaceutical, orally applicable composition
ATE505183T1 (de) Den geschmack verdeckende auslaufsichere formulierung
AP1595A (en) Pharmaceutical formulation having a masked taste and method for the production thereof.
MXPA04005783A (es) Formulacion farmaceutica que comprende ciclosporina y uso de la misma.
WO2002043706A3 (en) Prolamin-based sustained-release compositions and delayed-onset compositions
BRPI0014878B8 (pt) composição farmacêutica contendo ciclosonida para aplicação à mucosa
DK1009380T3 (da) Fremgangsmåde til fremstilling af farmaceutiske formuleringer
CA2380757A1 (en) Pharmaceutical agent comprising a benzamide derivative as active ingredient
HRP20050342B1 (hr) Farmaceutska formulacija olanzapina
SE0001916D0 (sv) Novel formulation
EP0814770A1 (en) Process for the preparation of a solid pharmaceutical dosage form
RU96120655A (ru) Композиция для профилактики и лечения гриппа и орви
CA2429793A1 (en) Interferon therapeutic effect enhancer
WO2002003973A3 (en) Compositions comprising isosorbide dinitrate and methods for treatment of anal fissure
EP0815851A3 (en) Method of reducing irritativeness of surface active agents and aqueous compositions with reduced irritativeness
BR0206371A (pt) Composição farmacêutica sólida solúvel em água não efervescente, composição farmacêutica lìquida oral, e, processo para a fabricação de uma composição granulada
FR2803521B1 (fr) Utilisation de l'acide tiludronique et de ses derives chez la volaille pour la preparation d'un medicament destine a prevenir et a traiter l'osteoporose

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20140506

Year of fee payment: 13

PBON Lapse due to non-payment of renewal fee

Effective date: 20150621